Skip to main content
. 2022 Mar 2;7(3):e007780. doi: 10.1136/bmjgh-2021-007780

Table 1E.

North American and Central American region countries: COVID-19 cases and deaths (data from 2 May 2021), data on the number of children screened and diseases included, and the overall impact of COVID-19 pandemic on newborn screening. Legend: N/A - The Question was left unanswered.

Country (region) Population (in millions) COVID-19 cases per million (in thousands) Deaths due to COVID-19
(per million)
Wave with more impact on the country Wave with more impact on NBS Average number of newborns per country (2015–2020; from 30 June of the initial and final year) Newborns screened/year/centre Number of diseases in NBS Impairment of NBS during the pandemic* Were there plans/guidelines for NBS during a pandemic
North and Central America
 Canada (Nova Scotia) 38.1 32.5 639 Both equally Both equally 385 533 17 000 21–30 Little No
 Canada (Alberta) 38.1 32.5 639 Second N/A 385 533 55 000 21–30 Little N/A
 USA (Texas) 332.6 99.8 1777 Second Second 3 900 750 0† 31 or more Moderate No
 USA (San Diego, California) 332.6 99.8 1777 Both equally Both equally 3 900 750 85 000 31 or more N/A N/A

*A 5-point Likert scale was used to determine the impairment (1=none, 2=little, 3=moderate, 4=a lot, 5=a great deal).

†0 newborn screened by the state. They are followed up by volunteer consultants.

N/A, not available; NBS, newborn screening.